Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer
Release Date:
Toni Choueiri describes the results of this renal cancer trial exploring rechallange with immune therapy
Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer